Journey Medical Corp
DERM Nasdaq
SEC CIK 1867066
Follow Journey Medical
Weekly email: filings, results
Revenue, last quarter
$18.9M
+11.2% vs same quarter last year
Net income
−$1.3M
+43.2% vs same quarter last year
EPS, diluted
−$0.05
+44.4% vs same quarter last year
Operating cash flow
−$3.4M
−44.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $61.2M | −$11.4M |
| FY24 | $55.1M | −$14.7M |
| FY23 | $59.7M | −$3.9M |
| FY22 | $71M | −$29.6M |
| FY21 | $63.1M | −$44M |
| FY20 | $44.5M | $5.3M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 65.8% | −13.3% | −18.7% |
| FY24 | 62.1% | −24.8% | −26.6% |
| FY23 | 61.6% | −3.5% | −6.5% |
| FY22 | 56.7% | −38.8% | −41.7% |
| FY21 | 49.2% | −55.2% | −69.7% |
| FY20 | 67.2% | 17.6% | 11.9% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$24.1M |
| FY23 | $240K |
| FY22 | −$33.5M |
| FY21 | - |
| FY20 | - |
| FY19 | - |
- Journey Medical
- Healthcare median
Show the numbers
| Year | Journey Medical | Healthcare median |
|---|---|---|
| FY25 | −18.7% | −30.6% |
| FY24 | −26.6% | −47% |
| FY23 | −6.5% | −58% |
| FY22 | −41.7% | −80.4% |
| FY21 | −69.7% | −71.8% |
| FY20 | 11.9% | −62.2% |
| FY19 | - | −46.2% |